Our top pick for
Aphria Inc (APHA) is a leading drug manufacturers-specialty & generic business based in the US. It opened the day at USD$7.0724 after a previous close of USD$7.06. During the day the price has varied from a low of USD$6.89 to a high of USD$7.09. The latest price was USD$6.92 (25 minute delay). Aphria is listed on the NASDAQ and employs 1,200 staff. All prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, Aphria's share price has had significant positive movement.
Its last close price was USD$6.92, which is 40.17% up on its pre-crash value of USD$4.14 and 254.87% up on the lowest point reached during the March crash when the shares fell as low as USD$1.95.
If you had bought USD$1,000 worth of Aphria shares at the start of February 2020, those shares would have been worth USD$552.17 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,504.34.
|52-week range||USD$1.95 - USD$8.88|
|50-day moving average||USD$7.1661|
|200-day moving average||USD$5.2981|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.299|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-19.25%|
|1 month (2020-12-16)||-14.04%|
|3 months (2020-10-16)||48.82%|
|6 months (2020-07-16)||36.49%|
|1 year (2020-01-16)||33.33%|
|2 years (2019-01-16)||4.06%|
|3 years (2018-01-16)||17.4418|
|5 years (2016-01-14)||714.02%|
Valuing Aphria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aphria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aphria's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Aphria shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||USD$191 million|
|Return on assets TTM||0.53%|
|Return on equity TTM||-5.89%|
|Market capitalisation||USD$2.1 billion|
TTM: trailing 12 months
There are currently 21.7 million Aphria shares held short by investors – that's known as Aphria's "short interest". This figure is 12.6% down from 24.8 million last month.
There are a few different ways that this level of interest in shorting Aphria shares can be evaluated.
Aphria's "short interest ratio" (SIR) is the quantity of Aphria shares currently shorted divided by the average quantity of Aphria shares traded daily (recently around 12.1 million). Aphria's SIR currently stands at 1.8. In other words for every 100,000 Aphria shares traded daily on the market, roughly 1800 shares are currently held short.
However Aphria's short interest can also be evaluated against the total number of Aphria shares, or, against the total number of tradable Aphria shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aphria's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Aphria shares in existence, roughly 80 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Aphria shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aphria.
Find out more about how you can short Aphria stock.
We're not expecting Aphria to pay a dividend over the next 12 months.
Over the last 12 months, Aphria's shares have ranged in value from as little as $1.95 up to $8.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aphria's is 2.6595. This would suggest that Aphria's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.